Latest News

A selection of recent news and views from Catapult Ventures follows...

Blueberry Therapeutics Limited closes £10m funding to support development of nanomedicines portfolio

Alderley Park, UK, 14 August 2018– Blueberry Therapeutics Limited, (“Blueberry Therapeutics”) a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections...

Nexus Labs announces seed funding from Catapult Ventures and BioCity to launch  SurgicalTeaching.com

Alderley Park, UK 1st August 2018.  Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, SurgicalTeaching.com a digital platform aimed at enhancing the learnin...

Abzena signs protein engineering agreement with NYU Langone Health

Cambridge, UK, 30 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has entered into a master s...

Innovate UK Announces Precision Medicines Innovation Fund

  Improving diagnosis and treatment of disease: new innovation fund UK businesses can apply for simultaneous grant funding and venture capital investment in precision medicine projects. Published 10 July 2018 F...

Abzena and Telix sign strategic manufacturing and bioconjugation agreement

Cambridge, UK and Melbourne, Australia, 2 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has...

From our portfolio

Kanichi Research Services

Healthcare

Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analy...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email